×

img Acces sibility Controls

Research Projects Banner

Research Projects

Development of an affordable, automated and field deployable, point of care and contained system for rapid diagnosis of TB caused by Mycobacterium tuberculosis

Implementing Organization

Institute of Technology (IIT), New Delhi
Principal Investigator
Prof Seyed E. Hasnain
Professor
|
Department of Biochemical Engineering & Biotechnology, Indian Institute of Technology (IIT), New Delhi, India
Kusuma School of Biological Science
CO-Principal Investigator
Prof Ravikrishnan Elangovan
Associate Professor
|
Department of Biochemical Engineering & Biotechnology, Indian Institute of Technology (IIT), New Delhi, India
Department of Biochemical Engg and Biotechnology

Project Overview

Tuberculosis (TB) is major global health burden causing 1.5 million deaths annually. Affordable and sensitive detection of TB is urgently required to catch 3x106 TB patients who are left undiagnosed. Definitive diagnostics of pulmonary TB is performed by confirming the presence of Mycobacterium tuberculosis (MTB) in sputum samples. Currently smear microscopy is the main diagnostic method used in India, which lacks desired sensitivity. The project aims to develop a field deployable, automated, affordable and rapid MTB diagnostics test-system called “iMC2 TB test”. This involves thinning of the sputum sample in a single use capture bottle preloaded with reagents and followed by immuno-magnetic enrichment of the MTB cells using an automated, portable device. Enriched MTB cells will be confirmed using an inbuilt fluorescent detector. Assay kit will be pre-packaged, designed to drastically minimize exposure of aerosol to clinical workers, would cost around 300-500 INR and will take about 60 minutes per sample.
Funding Organization
Funding Organization
Ministry of Health and Family Welfare (MoHFW), Govt. of India
Quick Information
Area of Research
Medical Sciences
Focus Area
Point of care diagnostic tests and surveillance systems for common non-communicable and Infectious diseases
Sanction Amount
₹ 2.28 Cr
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop